ACAD
36.63
-1.54
-4.03%
AEMD
7.59
+0.54
+7.66%
APRI
1.7
+0.35
+25.93%
ARNA
2.71
0.00
0.00%
ATEC
0.575
+0.035
+6.481%
CNAT
3.93
-0.12
-2.96%
CRXM
0.37
0.00
0.00%
CYTX
0.362
+0.047
+14.9524%
DXCM
94.14
-0.05
-0.05%
GNMK
10.34
+0.32
+3.19%
HALO
17.46
-0.95
-5.16%
ILMN
197.61
-4.09
-2.03%
INNV
0.148
0.00
0.00%
INO
7.49
-0.24
-3.10%
ISCO
3.9
-0.08
-2.01%
ISIS
50.18
-1.36
-2.64%
LGND
91.94
-3.1
-3.26%
LPTN
0.23
+0.01
+2.22%
MBVX
1.75
+0.06
+3.86%
MEIP
1.82
+0.09
+5.20%
MNOV
2.95
+0.01
+0.34%
MRTX
25.82
-0.84
-3.15%
MSTX
0.485
+0.015
+3.191%
NBIX
46.38
-0.29
-0.62%
NUVA
52.72
-1.03
-1.92%
ONCS
5.38
+0.18
+3.46%
ONVO
2.73
+0.19
+7.48%
OREX
2.77
-0.12
-4.15%
OTIC
22.67
-0.83
-3.53%
QDEL
20.59
+0.14
+0.68%
RCPT
231.96
0.00
0.00%
RGLS
8.33
+0.06
+0.73%
RMD
51.94
-0.53
-1.01%
SCIE
0.014
0.00
-2.7586%
SPHS
0.9
+0.01
+1.12%
SRNE
12.68
-0.97
-7.11%
TROV
5.95
-0.38
-6.00%
VICL
0.59
+0.00
+0.0339%
VOLC
18
0.00
0.00%
ZGNX
19.22
+0.81
+4.40%
ACAD
36.63
-1.54
-4.03%
AEMD
7.59
+0.54
+7.66%
APRI
1.7
+0.35
+25.93%
ARNA
2.71
0.00
0.00%
ATEC
0.575
+0.035
+6.481%
CNAT
3.93
-0.12
-2.96%
CRXM
0.37
0.00
0.00%
CYTX
0.362
+0.047
+14.9524%
DXCM
94.14
-0.05
-0.05%
GNMK
10.34
+0.32
+3.19%
HALO
17.46
-0.95
-5.16%
ILMN
197.61
-4.09
-2.03%
INNV
0.148
0.00
0.00%
INO
7.49
-0.24
-3.10%
ISCO
3.9
-0.08
-2.01%
ISIS
50.18
-1.36
-2.64%
LGND
91.94
-3.1
-3.26%
LPTN
0.23
+0.01
+2.22%
MBVX
1.75
+0.06
+3.86%
MEIP
1.82
+0.09
+5.20%
MNOV
2.95
+0.01
+0.34%
MRTX
25.82
-0.84
-3.15%
MSTX
0.485
+0.015
+3.191%
NBIX
46.38
-0.29
-0.62%
NUVA
52.72
-1.03
-1.92%
ONCS
5.38
+0.18
+3.46%
ONVO
2.73
+0.19
+7.48%
OREX
2.77
-0.12
-4.15%
OTIC
22.67
-0.83
-3.53%
QDEL
20.59
+0.14
+0.68%
RCPT
231.96
0.00
0.00%
RGLS
8.33
+0.06
+0.73%
RMD
51.94
-0.53
-1.01%
SCIE
0.014
0.00
-2.7586%
SPHS
0.9
+0.01
+1.12%
SRNE
12.68
-0.97
-7.11%
TROV
5.95
-0.38
-6.00%
VICL
0.59
+0.00
+0.0339%
VOLC
18
0.00
0.00%
ZGNX
19.22
+0.81
+4.40%
Home » Archive by Category

Xconomy

“Global Health” Must Mean Global Health

July 9, 2015 – 3:20 am

The research community and pharmaceutical industry have made many life-saving and life-improving advances in global health over the past 20 years, and that’s certainly life-affirming news. But the…

[[Click headline to continue reading.]]

For Biotech Cowboys, It’s No Ride Into The Sunset

July 8, 2015 – 10:48 am

[Corrected 7/8/15, 3:48pm. See below.] Some people who’ve made it big in biotech drive fast cars. Some take outlandish vacations. Some don’t take any vacations at all. (I’m sure you…

[[Click headline to continue reading.]]

UCSD Asks Court to Restore Custody and Control of Alzheimer’s Data

July 7, 2015 – 6:24 pm

If there’s anything that’s clear in the recent donnybrook between UC San Diego and the University of Southern California, it’s that a 24-year study known as the Alzheimer’s Disease Cooperative Study…

[[Click headline to continue reading.]]

West Health COO Shelley Lyford to Succeed Nick Valeriani as CEO

July 7, 2015 – 5:00 am

West Health CEO Nick Valeriani plans to retire in September, after three years overseeing the San Diego-based nonprofit medical research organization founded by the Nebraska telemarketing billionaire…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More

July 6, 2015 – 3:33 pm

It was a short work week leading up to the 4th of July, but it was long on news out West. There were plenty of fireworks of the legal, political, and financial variety, with an academic lawsuit in…

[[Click headline to continue reading.]]

Biopharmaceutical Haiku, Round Two

July 6, 2015 – 12:00 am

Ebola doctors Heroic efforts admired Angels of mercy!   Genome sequencing Compare normal with patient Secrets revealed   Next-gen sequencing One big issue still out there Interpretation…

[[Click headline to continue reading.]]

Prenatal Tester Natera Now Shooting for $175M IPO

July 1, 2015 – 10:59 am

Natera of San Carlos, CA, has bumped the fundraising goal for its upcoming IPO to $175 million, according to a document filed today with the Securities and Exchange Commission. The maker of…

[[Click headline to continue reading.]]

AstraZeneca Working with Eolas Therapeutics on Anti-Addiction Drug

June 30, 2015 – 3:11 pm

Eolas Therapeutics, a Carlsbad, CA-based startup developing new drugs for treating addiction, said it has signed a global licensing and partnership agreement with AstraZeneca (NYSE: AZN) to advance…

[[Click headline to continue reading.]]

Out of the Digital Health Fog, More Investments Are Coming in 2015

June 28, 2015 – 10:45 pm

Venture capitalists have been talking up the rewards of digital health for some time now, and we are certainly putting our money where our mouth is. Record-breaking dollars continue to flow into…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More

June 26, 2015 – 11:45 am

It was a big week across the nation for Xconomy’s biotech coverage. We launched Exome, a redesigned site with more stories, livelier graphics, and other features to give readers a more…

[[Click headline to continue reading.]]